New treatment option for Ridge Preservation
Official title Comparison of Two Types of Bone Grafts in Patients Who Need One of Their Front Teeth Removed and Replaced With an Implant
ClinicalTrials.gov ID: NCT06722482
What this study is testing
- What it's testing
- The purpose of this study is to compare two different bone graft materials (freeze-dried bone allograft, FDBA and collagen-enriched bovine xenograft, CEBX) that are routinely used for preserving the remaining bone after extraction of an anterior tooth, and before placing a dental implant. Patients will be randomly assigned to either group (flip of a coin) One group will receive FDBA material and the other group will receive CEBX (cow) material.
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- patients able to provide informed consent
- patients of 18 years of age or older at time of consent and enrollment
- patients in need of at least one anterior tooth extraction and seeking dental implant replacement
- bone on the buccal of the central/lateral incisors or canines planned for extraction that is either intact or has a dehiscence \</=5mm as determined...
You likely can't join if
- current smokers or tobacco-product users (self-reported)
- uncontrolled diabetes (HbA1c≥7 in the last 3 months)
- pregnant and/or lactating females (self-reported)
- patients on immunosuppressants, steroids, bisphosphonates or other medications that have been related to Medication-Related Osteonecrosis of the Jaw...
- patients with history of radiation of the head and neck
- patients with allergy to collagen, bacitracin and/or polymyxin B
See the full eligibility criteria
- patients able to provide informed consent
- patients of 18 years of age or older at time of consent and enrollment
- patients in need of at least one anterior tooth extraction and seeking dental implant replacement
- bone on the buccal of the central/lateral incisors or canines planned for extraction that is either intact or has a dehiscence \</=5mm as determined radiographically through cone beam computed tomography (CBCT)
- current smokers or tobacco-product users (self-reported)
- uncontrolled diabetes (HbA1c≥7 in the last 3 months)
- pregnant and/or lactating females (self-reported)
- patients on immunosuppressants, steroids, bisphosphonates or other medications that have been related to Medication-Related Osteonecrosis of the Jaw (MRONJ) as described by the American Association of Oral Maxillofacial...
- patients with history of radiation of the head and neck
- patients with allergy to collagen, bacitracin and/or polymyxin B
- patients with religious or cultural beliefs that prohibit the use of either allograft or bovine graft material
- patients with physical and/or mental/cognitive disabilities (self-reported) or decisionally-impaired, not able to consent for themselves
- patients with untreated periodontitis
- patients with central/lateral incisors or canines requiring extraction and are adjacent to an edentulous area
- patients with central/lateral incisors or canines with buccal bone dehiscence \>5mm
The study team makes the final eligibility decision.
Where it's taking place
- Rochester, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rochester, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.